At a glance
ClinicalIndex Comparison RecordN/ACompleted· 32 enrolled
Drug / intervention
NGENUITY +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparing NGENUITY vs Conventional Microscope in a New Hydrus User
In Brief
A clinical study evaluating NGENUITY and Conventional microscope for Glaucoma. Completed, enrolled 32 participants across 1 site.
Detailed Summary
To compare the potential efficiency and educational value of using NGENUITY (3D camera system, FDA approved for this indication) vs the conventional microscope for Hydrus microstent placement by new users.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma
CountriesUnited States
CollaboratorsAlcon Research
Timeline
N/ACompletedFinished
2023202420252026
First PostedSep 2022
Enrollment StartFeb 2023
Primary CompletionMar 2024
TodayJul 2026
First PostedSep 7, 2022
Enrollment StartFeb 13, 2023
Primary CompletionMar 22, 2024
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 3.8 years ago
Interventions
NGENUITYdevice
Device for 3-D viewing during placement of micro-stent placement.
Conventional microscopedevice
Device for stereoscopic viewing during placement of micro-stent placement.